Literature DB >> 2828139

Insulin resistance in type 1 (insulin-dependent) diabetes following hypoglycaemia--evidence for the importance of beta-adrenergic stimulation.

S Attvall1, J Fowelin, H von Schenck, I Lager, U Smith.   

Abstract

The insulin effect, evaluated with the euglycaemic clamp technique, was studied before and after hypoglycaemia in 7 patients with Type 1 (insulin-dependent) diabetes. Following an initial 2 h clamp (clamp I) hypoglycaemia was induced and 2 h later a second clamp (clamp II), identical to the former, was performed. Each subject was studied twice; during infusion with saline (placebo) or propranolol. Glucose production and disposal were studied with the 3(3H)glucose technique. During placebo infusion, hypoglycaemia elicited an insulin resistance leading to approx. 50% reduction in the steady state glucose infusion rate during clamp II as compared to clamp I (clamp I 2.58 +/- 0.32, clamp II 1.26 +/- 0.08 mg . kg-1 . min-1, p less than 0.02). The insulin resistance was prevented by infusing propranolol (clamp I 2.29 +/- 0.29, clamp II 2.85 +/- 0.56 mg . kg-1 . min-1). The posthypoglycaemic insulin resistance was due to a less pronounced insulin effect on both glucose production (clamp I 0.29 +/- 0.21, clamp II 0.86 +/- 0.19 mg . kg-1 . min-1, p less than 0.05) and glucose utilisation (clamp I 2.84 +/- 0.26, clamp II 2.13 +/- 0.23 mg . kg-1 . min-1, p less than 0.05). The insulin resistance on both glucose production and utilisation was prevented by propranolol. Thus, the present study demonstrates that hypoglycaemia elicits a prolonged insulin resistance which is due to a less pronounced effect of insulin to both inhibit splanchnic glucose production and to stimulate peripheral glucose utilisation. The insulin resistance is due to beta-adrenergic stimulation and can be prevented by propranolol.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2828139     DOI: 10.1007/BF00296990

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  42 in total

1.  Production and characterization of an antiserum against pancreatic glucagon.

Authors:  H Von Schenck
Journal:  Clin Chim Acta       Date:  1977-11-01       Impact factor: 3.786

2.  Rarity of a marked "dawn phenomenon" in diabetic subjects treated by continuous subcutaneous insulin infusion.

Authors:  J J Bending; J C Pickup; A C Collins; H Keen
Journal:  Diabetes Care       Date:  1985 Jan-Feb       Impact factor: 19.112

3.  Enhanced glucose utilization during prolonged glucose clamp studies.

Authors:  L Doberne; M S Greenfield; B Schulz; G M Reaven
Journal:  Diabetes       Date:  1981-10       Impact factor: 9.461

4.  Experimental validation of measurements of glucose turnover in nonsteady state.

Authors:  J Radziuk; K H Norwich; M Vranic
Journal:  Am J Physiol       Date:  1978-01

5.  Effect of cardioselective and non-selective beta-blockade on the hypoglycaemic response in insulin-dependent diabetics.

Authors:  I Lager; G Blohmé; U Smith
Journal:  Lancet       Date:  1979-03-03       Impact factor: 79.321

6.  In search of the Somogyi effect.

Authors:  E A Gale; A B Kurtz; R B Tattersall
Journal:  Lancet       Date:  1980-08-09       Impact factor: 79.321

7.  Diabetic autonomic neuropathy. The diagnostic value of heart rate monitoring.

Authors:  J D Mackay; M M Page; J Cambridge; P J Watkins
Journal:  Diabetologia       Date:  1980-06       Impact factor: 10.122

8.  Cortisol-induced insulin resistance in man: impaired suppression of glucose production and stimulation of glucose utilization due to a postreceptor detect of insulin action.

Authors:  R A Rizza; L J Mandarino; J E Gerich
Journal:  J Clin Endocrinol Metab       Date:  1982-01       Impact factor: 5.958

9.  Epinephrine plasma metabolic clearance rates and physiologic thresholds for metabolic and hemodynamic actions in man.

Authors:  W E Clutter; D M Bier; S D Shah; P E Cryer
Journal:  J Clin Invest       Date:  1980-07       Impact factor: 14.808

10.  Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. National Diabetes Data Group.

Authors: 
Journal:  Diabetes       Date:  1979-12       Impact factor: 9.461

View more
  3 in total

1.  Levodopa reduces risk factors for vascular disease in parkinsonian patients.

Authors:  Giulio Scigliano; Gabriele Ronchetti; Floriano Girotti; Massimo Musicco
Journal:  J Neurol       Date:  2008-05-30       Impact factor: 4.849

2.  Transient insulin resistance following infusion of adrenaline in type 1 (insulin-dependent) diabetes mellitus.

Authors:  M Kollind; U Adamson; P E Lins; B Hamberger
Journal:  Diabetologia       Date:  1988-08       Impact factor: 10.122

3.  Mechanisms of insulin resistance after insulin-induced hypoglycemia in humans: the role of lipolysis.

Authors:  Paola Lucidi; Paolo Rossetti; Francesca Porcellati; Simone Pampanelli; Paola Candeloro; Anna Marinelli Andreoli; Gabriele Perriello; Geremia B Bolli; Carmine G Fanelli
Journal:  Diabetes       Date:  2010-03-18       Impact factor: 9.461

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.